Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-965-8 | CAS number: 112-38-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Five studies on genetic toxicity on undecylenic acid were carried out in the years 1988 and 1989. Four in vitro GLP tests were performed according to corresponding OECD guidelines for the ames test, the cytogenicity test, the in vitro mammalian cell gene mutation and the in vitro DNA repair assay. All tests were negative.
Link to relevant study records
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1989-07-21 till 1998-09-29
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Version / remarks:
- 1981
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.10 (Mutagenicity - In Vitro Mammalian Chromosome Aberration Test)
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- in vitro mammalian chromosome aberration test
- Species / strain / cell type:
- lymphocytes: human
- Details on mammalian cell type (if applicable):
- - Type and identity of media: HEPES-buffered RPMI, 20% FCS, 50 ug/ml Gentamycin
- Properly maintained: yes
- Phytohaemaglutinine for stimulation (0.1 ml/10 ml culture) - Metabolic activation:
- with and without
- Metabolic activation system:
- S 9 (Arochlor-induced rat liver)
- Test concentrations with justification for top dose:
- 211.25, 325 and 500 µg/ml
- Vehicle / solvent:
- DMSO
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- Remarks:
- Migrated to IUCLID6: and methylmethanesulphonate
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium in suspension;
DURATION
- Preincubation period: 44 h
- Exposure duration: 3 h
- Fixation time (start of exposure up to fixation or harvest of cells): 3 h (methanol and glacial acetic acid)
SPINDLE INHIBITOR (cytogenetic assays): Colchicine 1 ug/ml added after 2 h to arrest cells in metaphase
STAIN (for cytogenetic assays): Gurr`s Giemase R66
NUMBER OF REPLICATIONS: one male and one female donor, control and all 4 doses with and without S9
NUMBER OF CELLS EVALUATED: 200 (min. 160) - Evaluation criteria:
- no data
- Statistics:
- no data
- Species / strain:
- lymphocytes: human
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Conclusions:
- Under the experimental conditions, the test substance undecylenic acid was unable to induce chromosome aberrations in human lymphocytes.
- Executive summary:
Undecylenic acid was tested in an in vitro cytogenetic assay according to OECD guideline 473 and EU method B10. The test substance, undecylenic acid, was applied to primary human lymphocyte cultures in the presence or absence of a metabolic activating system (rat liver S9). Treatment of cells with the test subtance in the presence or absence of S9 resulted in similar numbers of aberrations compared to negative controls, while cell cultures treated with positive control substances resulted in significant elevation of aberrations. Under the experimental conditions, the test substance undecylenic acid was unable to induce chromosome aberrations in human lymphocytes.
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- 1981
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- Histidine operon
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Species / strain / cell type:
- S. typhimurium TA 1538
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 -mix from Arochlor-induced rats
- Test concentrations with justification for top dose:
- 10, 50, 100, 250, 500 and 750 µg/ml (genotox);
(bacterial toxicity testing up to 5000 µg/ml) - Vehicle / solvent:
- DMSO
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: and 2-nitrofluorene, sodium azide, 2-aminoanthracene with S9
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation)
DURATION
- Preincubation period: 20 min.
-Substance Exposure and colony growth (selection): 48h
SELECTION AGENT (mutation assays): histidine-depletion
NUMBER OF REPLICATIONS: 2 studies, each triplicate
DETERMINATION OF CYTOTOXICITY
- Method: counting of formed colonies - Evaluation criteria:
- no data
- Statistics:
- no data
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- not precised
- Vehicle controls validity:
- not specified
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Conclusions:
- In conclusion, undecylenic acid was under the experimental conditions not genotoxic in the AMES test.
- Executive summary:
The potential genotoxicity of undecylenci acid was tested by AMES test according to OECD guideline 471 and EU method B.13/14 in five tester strains of salmonella typhimurium. Bacterial cultures were treated with the test substance in the presence and absence of a metabolically activating system (rat liver S-9). Whether in the presence or absence of metabolic activation, no increase was observed in the number of His+-revertant colonies/plate at any of the dose levels tested an any tester strain. In conclusion, undecylenic acid was under the experimental conditions not genotoxic in the AMES test.
- Endpoint:
- in vitro DNA damage and/or repair study
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 482 (Genetic Toxicology: DNA Damage and Repair, Unscheduled DNA Synthesis in Mammalian Cells In Vitro)
- Version / remarks:
- 1986
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.18 (DNA Damage and Repair - Unscheduled DNA Synthesis - Mammalian Cells In Vitro)
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- DNA damage and repair assay, unscheduled DNA synthesis in mammalian cells in vitro
- Species / strain / cell type:
- hepatocytes: rat
- Details on mammalian cell type (if applicable):
- no
- Metabolic activation:
- without
- Test concentrations with justification for top dose:
- test no1 : 1, 5, 10, 25, 50 and 100 µg/ml
test no2 : 10, 25, 50 and 100 µg/ml - Vehicle / solvent:
- DMSO
- Untreated negative controls:
- yes
- Remarks:
- untreated
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- yes
- Remarks:
- pyren (0.1 mM)
- Positive controls:
- yes
- Positive control substance:
- other: 2-aminofluoren (0.01 and 0.05 mM)
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: preincubation
DURATION
- Preincubation period: no data
- Exposure duration: 18-20 hours
NUMBER OF REPLICATIONS: 3 cell cultures
NUMBER OF CELLS EVALUATED: 20 cells/slide
DETERMINATION OF CYTOTOXICITY : yes in preliminary study
OTHER EXAMINATIONS:
- Determination of polyploidy: no data
- Determination of endoreplication: no data - Evaluation criteria:
- The result is considered positive when the average nuclear grains in the treated cultures is significantly different from controls and when number of grains in the nucleus subtracted from the number of grains obtained in the cytoplasm was higher than 3.
- Statistics:
- The test results of DNA repair were quantified by determining the average grain nuclear and cytoplasmic grains, with the standard error in each case.
- Species / strain:
- lymphocytes: rats
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- at 100 µg/ml and more
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- See tables
- Conclusions:
- Under the experimental conditions, no signs of genotoxicity could be found for the test substance undecylenic acid.
- Executive summary:
Undecylenic acid was tested in an in vitro DNA-repair test system for potential genotoxicity acoording to OECD guideline 482 / EU method B.18.
Primary rat hepatocytes cell cultures were treated with the test substance. The amount of thymidine-incorporation into DNA was equivalent in control cell cultures and in cell cultures treated with the test substance up to 500 ug/ml, while thymidine-uptake was significantly increased in cell cultures treated with a positive control substance.
Under the experimental conditions, no signs of genotoxicity could be found for the test substance undecylenic acid.
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Version / remarks:
- 1984
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.17 (Mutagenicity - In Vitro Mammalian Cell Gene Mutation Test)
- GLP compliance:
- yes
- Type of assay:
- mammalian cell gene mutation assay
- Target gene:
- hypoxanthine-phosphoribosyl-transferase (HPRT)
- Species / strain / cell type:
- Chinese hamster lung fibroblasts (V79)
- Details on mammalian cell type (if applicable):
- - Type and identity of media: DMEM 10% FCS, Pen/Strep/fungizone
- Properly maintained: yes
-obtained as cryopreserved stock from Institute de Recherches Scientifiques sur le Cancer, Villejuif, France - Metabolic activation:
- with and without
- Metabolic activation system:
- S 9 (from the liver of Arochlor-induced rats)
- Test concentrations with justification for top dose:
- 10, 30, 100, 300, 500, 600 µg/ml
- Vehicle / solvent:
- DMSO
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- N-ethyl-N-nitro-N-nitrosoguanidine
- Remarks:
- and Dimethylnitrosamin with S9
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium; in agar (plate incorporation); preincubation; in suspension; as impregnation on paper disk
DURATION
- Preincubation period:
- Exposure duration: 3 h
- Expression time (cells in growth medium): 6 days
- Selection time (if incubation with a selection agent): 10 days on 6-thioguanine
STAIN (for cytogenetic assays): Giemsa
NUMBER OF REPLICATIONS: 2 studies (6 and 10 replicates/condition, respectively)
DETERMINATION OF CYTOTOXICITY
- Method: cloning efficiency; - Evaluation criteria:
- Mutagen if: 3 times mutation frquency of untreated cells + dose-dependent, statistically significant increase in mutation frequency + reproducible in repeat-experiment
- Statistics:
- no data
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Remarks:
- up to limit of solubility
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- >= 500 µg/ml in the presence of S9
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Water solubility: <= 500 µg/ml - Conclusions:
- Under the described experimental conditions, the test substance undecylenic acid is not mutagenic in the chinese hamster V79/HPRT gene mutation assay.
- Executive summary:
The in vitro mutagenic activity of the test substance undecylenic acid was investigated in the chinese hamster V79/HPRT-test. The test substance was applied to cell cutures at concentrations of 30 -500 ug/ml in the presence or absence of metabolic activation system (S9 -mix). The mutation frequency of treated cell cultures was equal to that of untreated controls, while cell cultures treated with positive controls presented higher mutation frequencies.
Under the described experimental conditions, the test substance undecylenic acid is not mutagenic in the chinese hamster V79/HPRT gene mutation assay.
Referenceopen allclose all
Results of test no1 :
Number of grains per cell |
Cytoplasmic grains per cell |
|
Batch no.0 : negative control (untreated) |
15+/-0.4 |
20+/-0.3 |
Batch no.1 : solvent control (DMSO) |
14+/-0.3 |
20+/-0.4 |
Batch no.2 : true negative control (pyren) |
16+/-0.5 |
23+/-0.3 |
Batch no.3 : positive control (2AF, 0.1nM/ml) |
82+/-1.9 |
15+/-0.3 |
Batch no.4 : positive control (2AF, 0.5nM/ml) |
97+/-2.3 |
13+/-0.3 |
Batch no.5 : undecylenic acid (100 µg/ml) |
14+/-0.4 |
18+/-0.5 |
Batch no.6 : undecylenic acid (50 µg/ml) |
13+/-0.4 |
19+/-0.5 |
Batch no.7 : undecylenic acid (25 µg/ml) |
14+/-0.5 |
21+/-0.5 |
N=60 |
Results of test no2 :
Number of grains per cell |
Cytoplasmic grains per cell |
|
Batch no.0 : negative control (untreated) |
19+/-0.5 |
23+/-0.4 |
Batch no.1 : solvent control (DMSO) |
20+/-0.4 |
25+/-0.4 |
Batch no.2 : true negative control (pyren) |
17+/-0.5 |
22+/-0.5 |
Batch no.3 : positive control (2AF, 0.1nM/ml) |
112+/-0.3 |
24+/-0.6 |
Batch no.4 : positive control (2AF, 0.5nM/ml) |
141+/-1.8 |
28+/-0.6 |
Batch no.5 : undecylenic acid (100 µg/ml) |
19+/-0.6 |
24+/-0.4 |
Batch no.6 : undecylenic acid (50 µg/ml) |
17+/-0.4 |
22+/-0.4 |
Batch no.7 : undecylenic acid (25 µg/ml) |
16+/-0.4 |
20+/-0.4 |
N=60 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Description of key information
A micronucleus test was performed in the mice according to GLP and OECD guideline. All tests gave negative results on genotoxicity of the test item.
Link to relevant study records
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1987-09-22 till 1987-12-16
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Version / remarks:
- 1893
- Deviations:
- no
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- EU Method B.12 (Mutagenicity - In Vivo Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- no
- Remarks:
- (bone marrow)
- GLP compliance:
- yes
- Type of assay:
- micronucleus assay
- Species:
- mouse
- Strain:
- CD-1
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Chalres River, Cléon, France
- Age at study initiation: 7 weeks
- Weight at study initiation: 29g (males) 22g (females)
- Housing: wire mesh bottom stainless steel cages
- Diet / Water (e.g. ad libitum): ad lib.
- Acclimation period:2 weeks
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22+/-2
- Humidity (%): 60+/-10
- Air changes (per hr): 12
- Photoperiod (hrs dark / hrs light): 12/12 - Route of administration:
- oral: gavage
- Vehicle:
- 10% gum arabic, freshly prepared
- Details on exposure:
- no
- Duration of treatment / exposure:
- single
- Frequency of treatment:
- single treatment on day 1
- Post exposure period:
- 24, 48 and 72 h
- Dose / conc.:
- 1 000 mg/kg bw/day
- Dose / conc.:
- 2 000 mg/kg bw/day
- Dose / conc.:
- 4 000 mg/kg bw/day
- No. of animals per sex per dose:
- 15
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- Cyclophosphamide ip (15 males and 15 females)
- Tissues and cell types examined:
- bone marrow smears
- Details of tissue and slide preparation:
- DETAILS OF SLIDE PREPARATION:
both femurs severed, bone marrow flushed out with calf`s serum, cells opbtained by mild centrifugation and spread over slides after mild homogenization; fixed with methanol and stained automatically
- Evaluation criteria:
- An increase in micronucleated polychromatic cells shows a possible genotoxic effect.
When the ratio PCE / NCE decreases, this represents marrow cytotoxicity. - Statistics:
- no
- Sex:
- male/female
- Genotoxicity:
- negative
- Remarks:
- for all doses similar to that of control animals
- Toxicity:
- yes
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF DEFINITIVE STUDY
- Ratio of PCE/NCE (for Micronucleus assay): similar for control and 24/48h-groups; 72 h not evaluated
- Appropriateness of dose levels and route: 3 cases of mortality (high dose, only males, 24/48h) - Conclusions:
- Under the experimental conditions, undecylenic acid did not reveal any in vivo genotoxic activity in the micronucleus test in mice.
- Executive summary:
The in vivo genotoxic potential of undecylenic acid was assessed in the mouse by micronucleus test according to OECD guideline 474 and EU method B.12. Undecylenic acid was administered once by oral gavage at dose levels of 1,2 and 4 g/kg bw to CD-1 mice. Each group consisted of 15 male and 15 female animals. Cyclophosphamide served as positive control.
No clinical signs were reported throughout the study, but three maled of the highest dose group were found dead 24 or 72 h after treatment. The PCE/NCE ratio obtained in all treated animals (24 and 48h after treatment) was similar to that of the control animals, and evaluation of the samples obtained 72 h after treatment was not considered necessary.
Under the experimental conditions, undecylenic acid did not reveal any in vivo genotoxic activity in the micronucleaus test in mice.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
Justification for classification or non-classification
Since all genotoxicity tests gave negative results, no classification of undecylenic acid is warranted for genotoxicity properties according to EU regulation (EC) No 1272/2008 (CLP).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
